Retina

SEATTLE — In the U.S. and Canada, the burden of geographic atrophy on patients and caregivers is “substantial and multifaceted,” according to a study presented at the American Society of Retina Specialists annual meeting.

SEATTLE — Cases of unexplained vision loss following silicone oil tamponade removal have been reported over the years. Potential causes have been investigated but remain unclear.

SEATTLE — In this Healio Video Perspective from OIS Retina, Nancy Lurker discusses an update on the ongoing phase 2 DAVIO 2 trial, as well as the demographic data in the completed phase 1 DAVIO 1 trial and the DAVIO 2 trial

SEATTLE — In this Healio Video Perspective from OIS Retina, Ronil Patel, MS, discusses Ocuphire Pharma’s end-of-phase 2 FDA meeting planned for later this year.

The American Academy of Ophthalmology IRIS Registry has now linked approximately 3.5 million ophthalmic images to deidentified electronic health record data from nearly 16,000 contributing clinicians.

RetinAI Medical and Retina Consultants of America have partnered to build an artificial intelligence-driven real-world evidence database, according to a press release.

Dr. Noemi Lois is my guest author today.

Healio’s top retina/vitreous items this week covered a license agreement between Astellas and 4D Molecular Therapeutics as well as a review of retinal vasculitis or vascular occlusion events following treatment with brolucizumab.

When faricimab became the first bispecific antibody approved by the FDA for use in ophthalmology, retina specialists who treat wet age-related macular degeneration and diabetic macular edema were presented with a new treatment option.